Kimberly-Clark KMB underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

In the assessment of 12-month price targets, analysts unveil insights for Kimberly-Clark, presenting an average target of $140.27, a high estimate of $165.00, and a low estimate of $118.00. Experiencing a 4.64% decline, the current average is now lower than the previous average price target of $147.10.

Diving into Analyst Ratings: An In-Depth Exploration

In examining recent analyst actions, we gain insights into how financial experts perceive Kimberly-Clark. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Kimberly-Clark. This information offers a snapshot of how analysts perceive the current state of the company.
• Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Kimberly-Clark compared to the broader market.
• Price Targets: Analysts predict movements in price targets, offering estimates for Kimberly-Clark's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

For valuable insights into Kimberly-Clark's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on Kimberly-Clark analyst ratings.

All You Need to Know About Kimberly-Clark

With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Kimberly-Clark: Delving into Financials

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.

Revenue Challenges: Kimberly-Clark's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -0.85%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.

Net Margin: Kimberly-Clark's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 9.07%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Kimberly-Clark's ROE stands out, surpassing industry averages. With an impressive ROE of 42.07%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): Kimberly-Clark's ROA stands out, surpassing industry averages. With an impressive ROA of 2.65%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Kimberly-Clark's debt-to-equity ratio is notably higher than the industry average. With a ratio of 9.02, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

The Basics of Analyst Ratings

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.